Fresenius SE & Co. (OTCMKTS:FSNUY) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) released its quarterly earnings data on Wednesday. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%.

Fresenius SE & Co. Stock Performance

Shares of FSNUY traded up $0.77 during mid-day trading on Wednesday, reaching $13.60. 25,247 shares of the company’s stock were exchanged, compared to its average volume of 152,604. The stock has a market capitalization of $30.64 billion, a PE ratio of 18.13 and a beta of 0.61. The business’s fifty day simple moving average is $11.69 and its 200-day simple moving average is $12.77. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98. Fresenius SE & Co. has a 52-week low of $10.33 and a 52-week high of $33.93.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Fresenius SE & Co. currently has an average rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.